This portal is a part of
Company Database with
22'833
Companies
23'639
Biotech / Medtech Products
3'000
Financing rounds
237
Company valuations
27'583
Management details
4'926
Licensing opportunities
Licensing Deals Database with
1'378
Deals each with financial information
Partners
Next Events
Feb 2012 - Zurich:
6th Swiss-Scandinavian Bio-Business Seminar
Mar 2012 - Haifa:
BioInvest Israel 2012
Mar 2012 - MUMBAI:
USFDA & EU Essentials of Drug Safety and Pharmacovigilance -
Add Event
Latest news
18 May 2011
Green light for Abunda acquisition
11 March 2011
Over 20’000 Company Profiles now available in the new Version of Biotechgate
ADVANCED SEARCH
Simple Search
|
A-Z Search
Company name
Free text
Canton
Main sector
-- select --
Biotechnology - Therapeutics and Diagnostics
Biotechnology / R&D Services
Biotechnology - other
Pharma
Medical Technology
Investor
Professional Services and Consulting
Public / Non-Profit Organizations
Supplier & Engineering
Media
Subsector*
Primary therapeutic areas*
Cardiovascular
Conditions originating in the perinatal period
Congenital malformations, deformations and chromosomal abnormalities
Digestive system
Diseases of the blood and blood-forming organs; immune disorders
Diseases of the ear
Diseases of the eye
Diseases of the nervous system
Endocrine, nutritional and metabolic diseases
External causes of morbidity and mortality
Genitourinary system
Infectious and parasitic diseases
Injury, poisoning and certain other consequences of external causes
Mental and behavioural disorders
Musculoskeletal system and connective tissue
Neoplasms / cancer / oncology
Pregnancy, childbirth and the puerperium
Respiratory
Skin and subcutaneous tissue
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Business Model*
Other
In-licensing
Manufacturer
Out-licensing
R&D
Research on contract basis
Service company
Subsidiary
Supplier / Distributor
Customer Segments*
Other
Consumers (mass market)
Hospitals
Large biotech & big pharma
Large medtech
Physicians / doctors
Small biotech
Small medtech
Distribution*
Direct (own sales force)
Indirect (independent dealer)
Products
Biotech
[all]
Medtech
[all]
Preclinical
In development
Phase I
On the market
Phase II
Phase III
On the market
Employees at domicil
from
to
Employees worldwide
from
to
Ownership*
Private / independent
Public
Subsidiary
* Multiple selection enabled: Hold down the CTRL key (PC) or the option key (Mac) to make multiple selections.
top
